Full-Time

President – Business Unit

Cordance

Cordance

51-200 employees

Acquires and scales vertical-focused B2B SaaS

No salary listed

Remote in USA

Remote

Category
Business & Strategy (1)
Required Skills
Sales

Get referred to Cordance

See people who can refer or advise you

Requirements
  • Proven experience as a President, General Manager, or senior P&L leader in a SaaS or B2B software environment.
  • Deep expertise in go-to-market strategy, product strategy, and customer success within a vertical SaaS or B2B context.
  • Strong track record of driving disciplined growth, scaling operations, and managing multi-million-dollar P&Ls.
  • Demonstrated ability to lead post-acquisition integrations, including systems, people, and GTM alignment.
  • Exceptional leadership skills with a focus on building teams, mentoring talent, and fostering accountability.
  • Strong financial and operational acumen, with the ability to balance long-term strategic vision and short-term execution.
  • Excellent communication, relationship-building, and stakeholder management skills.
  • Please note that we do not accept unsolicited resumes, work on a Corp-to-Corp basis, or engage with non-vetted external agencies.
Responsibilities
  • Serve as the primary product and market expert for the BU, with deep knowledge of customer needs, industry trends, and competitive dynamics.
  • Define and own the BU’s vision, objectives, and long-term growth strategy, aligning with Cordance’s portfolio priorities.
  • Develop and execute the annual operating plan and multi-year investment model, ensuring financial rigor and sustainable results.
  • Own full P&L responsibility, balancing growth initiatives with disciplined cost management.
  • Lead BU go-to-market strategy, including demand generation, sales execution, and revenue expansion.
  • Shape the product roadmap in alignment with market opportunities, customer feedback, and Cordance’s strategic framework.
  • Partner with Cordance operations to embed best practices in pricing, packaging, customer success, and GTM execution.
  • Act as the external face of the BU and Cordance to customers, partners, and industry stakeholders.
  • Take ownership of integration strategies for newly acquired businesses, including: Systems integration (data, platforms, shared services); GTM integration (messaging, demand gen, sales alignment); People integration (onboarding, organizational readiness, culture alignment).
  • Ensure milestones are met, risks are managed, and value creation targets are achieved during and after integration.
  • Drive operational excellence across engineering, product delivery, and customer-facing teams.
  • Build, lead, and mentor high-performing teams that embody accountability, innovation, and collaboration.
  • Foster a culture of growth, customer obsession, and operational discipline within the BU.
  • Develop leadership talent and ensure organizational structures scale with business growth.
  • Serve as the primary external and internal leader for the BU, representing Cordance with employees, customers, partners, and within the broader industry ecosystem.

Cordance buys and grows founder-run, vertically focused B2B SaaS companies using private equity, typically targeting under $10M ARR. It provides financial backing, operational support, and go-to-market leadership, while each acquired company remains its own unit. The portfolio spans industrial distribution, manufacturing, education technology, and secondhand retail, with cross-portfolio collaboration to accelerate growth. The goal is to create durable, long-term value by combining founder insight with strategic ownership and operational excellence.

Company Size

51-200

Company Stage

N/A

Total Funding

N/A

Headquarters

Raleigh, North Carolina

Founded

2021

Get referred to Cordance

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Cordance acquired RT Systems on March 19, 2026, expanding distribution software breadth.
  • AppsAnywhere joined on October 9, 2025, linking higher-ed delivery with LabStats analytics.
  • Cordance listed 18 open roles in June 2026, signaling active hiring across divisions.

What critics are saying

  • Rapid add-ons like Royal 4, RT Systems, and AppsAnywhere strain integration by 2027.
  • Autonomous units preserve culture but fragment product roadmaps, pricing, and support ownership.
  • A failed integration cycle kills founder trust and shuts off future deal flow.

What makes Cordance unique

  • Cordance buys niche SaaS like RT Systems, Royal 4, and AppsAnywhere, then leaves them autonomous.
  • It specializes in sub-$10 million ARR vertical software, a crowded buyer-universe many PE firms ignore.
  • Cordance's 2026 portfolio spans industrials, education, and resale, creating cross-sell density across units.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

401(k) Company Match

401(k) Retirement Plan

Unlimited Paid Time Off

Parental Leave

Remote Work Support

Paid Holidays

Growth & Insights and Company News

Headcount

6 month growth

1%

1 year growth

4%

2 year growth

20%
Bio-IT World
Mar 11th, 2026
DoseMe Appoints Richard Malone, PharmD, MHA, as Vice President, Clinical & Science

DoseMe Appoints Richard Malone, PharmD, MHA, as Vice President, Clinical & Science. March 11, 2026 Seasoned pharmacy and healthcare technology leader to oversee clinical strategy, biostatistics and scientific innovation JUPITER, FL- March 12, 2026 - DoseMe, a global leader in model-informed precision dosing (MIPD) software, today announced the appointment of Richard Malone, PharmD, MHA, as Vice President, Clinical & Science. In this role, Malone will lead the company's clinical and scientific initiatives, including oversight of biostatistics, clinical content development, and alignment of scientific strategy with DoseMe's broader growth objectives, including integration of newly acquired capabilities from Firstline. The combined platform of DoseMe and Firstline unifies evidence-based antimicrobial selection with Bayesian model-informed precision dosing within a single, streamlined clinical workflow. Together, the integrated solution enables health systems to align stewardship strategy, prescribing guidance, and individualized dosing optimization to improve outcomes, reduce resistance risk, and enhance operational efficiency. "Richard's unique combination of frontline clinical expertise, operational leadership, and healthcare technology experience strengthens DoseMe's ability to deliver scientifically rigorous, clinically practical precision dosing solutions," said John Hardesky, CEO of DoseMe. "As we expand our platform with the integration of Firstline's clinical decision support capabilities, his leadership positions us to further advance Bayesian modeling and unified antimicrobial stewardship solutions for health systems worldwide." Malone brings more than 30 years of leadership experience spanning hospital pharmacy operations, investigational drug services, healthcare software, and executive sales leadership. Malone will manage the team of biostatisticians responsible for building and advancing clinical models within the DoseMe platform and serve as the company liaison to the DoseMe Clinical Advisory Board. He will also play a key role in ensuring alignment between scientific innovation and the company's strategic roadmap. "I'm excited to join DoseMe at a time when precision dosing and model-informed drug therapy are becoming central to modern antimicrobial stewardship and patient safety," said Malone. "I look forward to strengthening the company's scientific foundation while supporting scalable growth." Most recently, Malone served as Vice President, Sales at Inovalon, where he led the Care Management business unit's national sales operations. Under his leadership, the team accelerated growth to $3.6 million in new annual contract value in 2024 and achieved greater than 100% net revenue retention, followed by 140% year-over-year ARR growth in the first half of 2025. Prior to Inovalon, Malone was president of McCreadie Group LLC, a healthcare software company acquired by Cordance Operations. During his tenure, the organization achieved 24% year-over-year growth and 28% EBITDA, while expanding its SaaS solutions supporting pharmaceutical research sites and pharmacy residency programs. Malone also brings deep academic medical center experience. He served for nearly a decade as Program Director of the Investigational Drug Service at Vanderbilt University Medical Center, where he led consolidation and expansion of research pharmacy services across the enterprise, improved quality metrics to over 99%, and transitioned the department to a positive operating margin within 12 months. Earlier in his career, he held executive pharmacy leadership roles including Director of Pharmacy at Centennial Medical Center and Maury Regional Medical Center, as well as Corporate Director of Pharmacy Operations for Vanguard Health Systems, overseeing pharmacy strategy across a 25-hospital system. Malone earned his Doctor of Pharmacy with honors from the University of Tennessee College of Pharmacy and a Master of Science in Health Care Administration from the University of Maryland University College. He completed his Pharmacy Practice Residency at Saint Thomas Hospital in Nashville, Tennessee. About DoseMe DoseMe is the provider of Firstline and DoseMeRx clinical decision support technologies that enable proactive, personalized care. Firstline is a mobile-first platform making treatment guidance accessible to every clinician, anywhere. DoseMeRx delivers clinically validated PK/PD models to individualize precision dosing in seconds. DoseMe's evidence-based clinical intelligence helps reduce adverse drug events, antibiotic overuse, improved adherence to stewardship guidance, and provides clinicians a clear path to optimal care. For more information and real-world success stories, visit https://doseme-rx.com/success-stories * News briefs American Journal of Health-System Pharmacy, 2021 * ASHP Executive Forums on Cold Chain Management of Pharmaceuticals in Health Systems American Journal of Health-System Pharmacy * SITC Appoints James Gulley as Vice President ASH Clinical News, 2022 * ASHP Distinguished Leadership Award Kate Traynor, American Journal of Health-System Pharmacy, 2022 * Appointment American Journal of Health-System Pharmacy, 2021

PR Newswire
Oct 9th, 2025
AppsAnywhere Joins Cordance to Boost Innovation

Cordance has acquired AppsAnywhere to enhance software access and delivery in higher education IT. This acquisition aims to expand capabilities in application delivery and IT efficiency, promoting digital equity for students. AppsAnywhere, trusted by over 300 institutions, will align with LabStats, another Cordance company, to optimize software delivery and usage analytics. This move supports higher education leaders in meeting diverse student expectations and improving IT efficiencies.

PR Newswire
Jan 22nd, 2024
Tequity Advises SaaS Supply Chain ERP Provider, Blue Link Associates, on Strategic Acquisition by Cordance

Blue Link Associates Limited, the all-in-one, wholesale distribution inventory management and accounting software system, partners with Cordance for growth

BuildCentrix
Nov 15th, 2023
Cordance Acquires BuildCentrix

Cordance Acquires BuildCentrix BuildCentrix, a leading construction workflow optimization and collaboration platform, partners with Cordance to accelerate growth

Cordance
May 24th, 2023
Cordance Completes Acquisition of Rubber Tree Systems – Cordance

Raleigh, NC, June 12, 2023: Today, Cordance announced the acquisition of Rubber Tree Systems, a SaaS solution provider specializing in sales execution and analytics for distribution and manufacturing professionals.